| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/16/2008 | EP1309585B1 Novel indole derivatives and their use as medicaments |
| 04/16/2008 | EP1250434B1 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 04/16/2008 | EP1250155B1 Angiogenesis and vascular permeability modulators and inhibitors |
| 04/16/2008 | EP1223952B1 Methods for treatment of solid tumors and metastasis by gene therapy |
| 04/16/2008 | EP1222289B1 Chimeric immunogenic compositions and nucleic acids encoding them |
| 04/16/2008 | EP1165549B1 C7 carbamoyloxy substituted taxanes as antitumor agents |
| 04/16/2008 | EP1108039B1 Elongase genes and uses thereof |
| 04/16/2008 | EP0922110B1 Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat |
| 04/16/2008 | CN101163710A Phosphine transition metal complex, process for producing the same and anticancer drug containing the same |
| 04/16/2008 | CN101163707A Thienopyridines |
| 04/16/2008 | CN101163694A Imidaz0l0-5-yl-2-anil0-pyrimidines as agents for the inhibition of cell proliferation |
| 04/16/2008 | CN101163691A 1,3-diaryl substituted ureas as modulators of kinase activity |
| 04/16/2008 | CN101163684A Quinazoline derivative having tyrosine kinase inhibitory activity |
| 04/16/2008 | CN101163503A Extending time to disease progression or survival in cancer patients using her dimerization inhibitor |
| 04/16/2008 | CN101163485A Method for treating advanced ovarian cancer with doxorubicin entrapped in liposomes |
| 04/16/2008 | CN101163473A Anticancer combination therapy using sunitinib malate |
| 04/16/2008 | CN101161670A Ursolic acid chemical modified compound amine having antitumor activity |
| 04/16/2008 | CN101161654A Antineoplastic active canthardin derivative and method for preparing same |
| 04/16/2008 | CN101161645A Urea derivatives as well as preparation method and uses thereof |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/16/2008 | CN101161629A 4'-substituted benzyloxy-phenyl butadiene derivatives and preparation and uses thereof |
| 04/16/2008 | CN101161297A Medical tectorial membrane shaped radiation NiTi alloy endovascular stent |
| 04/16/2008 | CN101161290A Beta-elemi alkene polyglycol amine derivant as well as its synthesis method and purpose |
| 04/16/2008 | CN101161288A Enganced tumour cell cracking article of oligonucleotide and method for treating knub |
| 04/16/2008 | CN101161283A New use of CMTM1-v17 and its antagon |
| 04/16/2008 | CN101161263A A Chinese medicine for treating leukaemia and its preparing method |
| 04/16/2008 | CN101161239A PLGA Gemcitabine sustained-release microsphere and its preparing method |
| 04/16/2008 | CN101161237A Steady cisplatin element lipoid plastid and method for preparing the same |
| 04/16/2008 | CN101161235A Dasatini sustained-release implants for treating entity knub |
| 04/16/2008 | CN101161234A Erlotinib sustained-release implants for treating entity knub |
| 04/16/2008 | CN100381566C Recombinant methods and materials for producing epothilone and eopthilone derivatives |
| 04/16/2008 | CN100381466C Human pifl gene, its coding protein and use thereof |
| 04/16/2008 | CN100381460C HER-2 analogue antigen epitope and peptide containing said epitope |
| 04/16/2008 | CN100381459C Adriamycin derivative and its preparing method and use |
| 04/16/2008 | CN100381457C 8beta-vinil-11beta-(¿¿mega-substitu¿¼do)alquil-estra-1 ,3,5(10)-trienos |
| 04/16/2008 | CN100381455C The novel antisense-oligos with better stability and antisense effect |
| 04/16/2008 | CN100381444C Silicon phthalocyanine compound and composite, their preparation and application thereof |
| 04/16/2008 | CN100381437C Compounds, compositions and methods |
| 04/16/2008 | CN100381434C Manufacturing method of traditional Chinese medicine formulation containing emblic leafflower fruit extract possessing anticancer, antibiotic actions |
| 04/16/2008 | CN100381428C Quinazolone and quinazolone compound and application thereof |
| 04/16/2008 | CN100381424C Biaryl sulfonamides and methods for using same |
| 04/16/2008 | CN100381173C Antitumor agents comprising a targeting portion and an immune response triggering portion |
| 04/16/2008 | CN100381172C Treating prostate cancer with anti-ErbB2 antibodies |
| 04/16/2008 | CN100381129C Antitumor animal medicine and its preparing method |
| 04/16/2008 | CN100381126C Treating agent of plant poly pentene alcohol gor liver damage |
| 04/16/2008 | CN100381065C Preparation method of anti-tumour mutation milk powder containing micro ash tree pollen, pine pollen, lucid ganoderma powder etc. |
| 04/16/2008 | CN100381064C Preparation method of anti-tumour mutation soybean milk powder containing micro ash tree pollen, pine pollen, lucid ganoderma powder etc. |
| 04/15/2008 | US7358415 comprises administering the hepatocytes or plasma cells or T cells to an animal after stimulation in vitro |
| 04/15/2008 | US7358386 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 04/15/2008 | US7358379 Steroid conjugates, preparation thereof and the use thereof |
| 04/15/2008 | US7358354 Administering genetically engineered vectors to modulate lymphocytes; transfecting macrophages; used for prophylaxis or treatments for cancers or immune-related disorders |
| 04/15/2008 | US7358351 Endothelial cell expression patterns |
| 04/15/2008 | US7358350 Oncogene, recombinant protein derived therefrom, and uses thereof |
| 04/15/2008 | US7358341 Secreted protein for use in diagnosis, prevention and treatment of thyroid gland disorders |
| 04/15/2008 | US7358338 Heme peptide |
| 04/15/2008 | US7358333 Polypeptides of the IFNα-5 gene |
| 04/15/2008 | US7358329 Antagonists to chaperonin 10 |
| 04/15/2008 | US7358273 For therapy of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, and degenerative diseases |
| 04/15/2008 | US7358272 Reduction of levels of tumor necrosis factor-alpha and/or inhibition of phosphodiesterase 4; treating cancer, especially various types of leukemia |
| 04/15/2008 | US7358266 Cyclopropyl and cyclobutyl epothilone analogs |
| 04/15/2008 | US7358265 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/15/2008 | US7358258 Prodrugs of an ERK protein kinase inhibitor |
| 04/15/2008 | US7358253 Indolylmaleimide derivatives |
| 04/15/2008 | US7358250 Pyrrolo[2,3-d]pyrimidines that modulate ACK1 activity |
| 04/15/2008 | US7358241 10-farnesyl-4,6,8-trihydroxy-dibenzodiazepin-11-one; ECO-4601; anticarcinogenic, antitumor agent; early stage of cancer; reducing side-effects on normal cells |
| 04/15/2008 | US7358233 Tetronic acid derivative |
| 04/15/2008 | US7358224 Class III SLRP agonists for the reduction of blood vessel formation |
| 04/15/2008 | US7358086 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products |
| 04/15/2008 | US7358074 Human phosphatase RET31, and variants thereof |
| 04/15/2008 | US7358056 Methods for modulating signal transduction mediated by TGF-β and related proteins |
| 04/15/2008 | US7358045 Using engrailed-2 (En-2) gene expression as a diagnostic and prognostic indicator of mammary gland cell proliferative disorders; antisense agents |
| 04/15/2008 | US7357936 immunostimulant (3-de-O-acylated monophosphoryl lipid A) adsorbed onto metallic salt (aluminium hydroxide or aluminium phosphate); second salt with antigen which elicits immune response to polypeptide or pathogen; Hepatitis, human papilloma virus |
| 04/15/2008 | US7357928 Proteins for treatment of cancer by administering antinucleolin |
| 04/15/2008 | US7357925 Method for treating disorders and diseases treatable with human fibroblast interferon |
| 04/15/2008 | US7357924 Nucleic acids/proteins/antibodies/mimetics for cell differentiation/prolilferation control |
| 04/15/2008 | CA2410303C Beta-amino acid nitrile derivatives |
| 04/15/2008 | CA2398389C Method for inhibiting a tumor |
| 04/15/2008 | CA2323239C Novel matrix metalloproteinase inhibitors and down-regulators |
| 04/15/2008 | CA2170379C Photosensitizers |
| 04/15/2008 | CA2114859C Cytotoxic and antiviral compound |
| 04/13/2008 | CA2606658A1 Compositions and methods for treating neurological disorders or damage |
| 04/10/2008 | WO2008043087A2 Bicyclic nitrogen-containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors |
| 04/10/2008 | WO2008043031A1 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression |
| 04/10/2008 | WO2008043019A1 8-substituted 2-(benzimidazolyl) purine derivatives for immunosuppression |
| 04/10/2008 | WO2008043018A1 Tumor immunity |
| 04/10/2008 | WO2008042928A2 Oxadiazole and thiadiazole derivatives as mitotic kinesin inhibitors and methods of use thereof |
| 04/10/2008 | WO2008042639A1 Compounds and compositions as protein kinase inhibitors |
| 04/10/2008 | WO2008042611A2 Method of using il6 antagonists with mitoxantrone for prostate cancer |
| 04/10/2008 | WO2008042508A1 Grp78 as a predictor of responsiveness to therapeutic agents |
| 04/10/2008 | WO2008042282A2 Imidazole-4, 5-dicarboxamide derivatives as jak-2 modulators |
| 04/10/2008 | WO2008041767A1 Gene/protein marker for prediction or diagnosis of pharmacological efficacy of aurora a inhibitor |
| 04/10/2008 | WO2008041665A1 Screening method for prophylactic and/or therapeutic agent for disease accompanied by hepatitis c |
| 04/10/2008 | WO2008041610A1 Compound of resorcinol derivative with polymer |
| 04/10/2008 | WO2008041514A1 Radiation sensitizer or anti-cancer chemotherapy sensitizer |
| 04/10/2008 | WO2008041264A1 Isoindolo-quinoxaline derivatives having antitumor activity, process for their production and their use |
| 04/10/2008 | WO2008041246A2 Injectable depot composition and its' process of preparation |
| 04/10/2008 | WO2008041236A2 Composition comprising crustacean gastrolith components, calcium carbonate and its use |
| 04/10/2008 | WO2008041037A1 Fused indoles and indazoles as inhibitors of poly(adp-ribose)polymerase (parp) |
| 04/10/2008 | WO2008040979A1 Arginine derivatives with np-i antagonistic activity |
| 04/10/2008 | WO2008040951A1 Compounds |